OR
MDT icon

Olympiad Research’s Medtronic MDT Stock Holding History

Olympiad Research’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,110
Closed -$248K – 322
2024
Q4 		$248K Buy
+3,110
New +$269K 0.26% 136
2020
Q2 		– Sell
-2,257
Closed -$204K – 360
2020
Q1 		$204K Buy
2,257
+325
+17% +$34.6K 0.21% 198
2019
Q4 		$219K Buy
+1,932
New +$212K 0.17% 187

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Olympiad Research's MDT Position: Q1 2025 in Review

Olympiad Research sold out of Medtronic (MDT) in Q1 2025, closing a stake of 3,110 shares — an estimated $248K sold.

Olympiad Research first reported a position in MDT in Q4 2019 and held it in 3 quarters. The position peaked at $248K in Q4 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Olympiad Research reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Olympiad Research sold 3,110 Medtronic shares in Q1 2025, an estimated $248K.
  • Olympiad Research first reported a position in Medtronic in Q4 2019 and held it in 3 quarters.
  • Olympiad Research's Medtronic position peaked at $248K in Q4 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Olympiad Research's 13F filing for Q1 2025, filed 13 May 2025.